Probiotics for the prevention of antibiotic-associated diarrhea in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 62, Issue 3, 2016, Pages 495-506

  Szajewska, Hania ^a   Canani, Roberto Berni ^b,c   Guarino, Alfredo ^b   Hojsak, Iva ^d   Indrio, Flavia ^e   Kolacek, Sanja ^d   Orel, Rok ^f   Shamir, Raanan ^g   Vandenplas, Yvan ^h   Van Goudoever, Johannes B ⁱ   Weizman, Zvi ^j  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Department of Translational Medical Science ^*  (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Croatia   (Croatia)

^e POLICLINICO   (Italy)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g TEL AVIV UNIVERSITY   (Israel)

^h UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

ⁱ EMMA CHILDREN S HOSPITAL   (Netherlands)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

more..

Author keywords

Clostridium difficile; Dysbiosis; Guideline; Infants; Microbiota; Probiotics; RCT; Systematic review

Indexed keywords

ANTIBIOTIC AGENT; KEFIR; PLACEBO; PROBIOTIC AGENT; YOGHURT; ANTIINFECTIVE AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; BACILLUS; BACILLUS CLAUSII; BACILLUS LACTIS; BACTERIAL CLEARANCE; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM INFANTIS; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; GROUPS BY AGE; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; META ANALYSIS; MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SACCHAROMYCES BOULARDII; STREPTOCOCCUS THERMOPHILUS; SYSTEMATIC REVIEW; TREATMENT DURATION; CHILD; DIARRHEA; INFANT; MICROBIOLOGY; PRESCHOOL CHILD;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DIARRHEA; GUIDELINES AS TOPIC; HUMANS; INFANT; PROBIOTICS; RISK FACTORS;

EID: 84960171850     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001081     Document Type: Review

References (42)

1. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ 2002;324:1345-6.
2. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
3. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
4. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22.
5. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14.
6. Szajewska H, Guarino A, Hojsak I, et al., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-9.
7. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011CD004827.
8. Guarner F, Khan AG, Garisch J, et al., World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46:468-81.
9. Grzes̈kowiak Ł, Isolauri E, Salminen S, et al. Manufacturing process influences properties of probiotic bacteria. Br J Nutr 2011;105:887-94.
10. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut 2013;62: 787-96.
11. Higgins JPT, Altman DG, Sterne AC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. www.cochrane-hand book.org. Published 2011. Accessed July 2015.
12. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
13. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719-25.
14. Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research. Guidance for industry: providing clinical evidence of effectiveness for human drug and biological products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryIn formation/Guidances/ucm078749.pdf. Published May 1998. Accessed July 2015.
15. Rijkers GT, Bengmark S, Enck P, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2010;140:671S-6S.
16. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307:1959-69.
17. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013;5:CD006095.
18. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatrics 1999;135:564-8.
19. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104:e64.
20. King SN, Chung AM, Vidal R. Randomized, double blind, placebo controlled trial to assess the efficacy of Lactobacillus GG in the prevention of antibiotic-associated diarrhea in the pediatric internsive care unit (PICU). Pharmacotherapy 2010;30:457-8.
21. Vaisanen LM, Leskinen M, Siitonen A, et al. Occurence of diarrhea in children receiving oral antibiotics with or without probiotic supplementation with Lactobacillus GG. Microb Ecol Health Dis 1998;10: 199-200.
22. Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, placebo-controlledtrial: effectoflactobacillusGGsupplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr 2009;48:431-6.
23. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21:583-90.
24. Casem RAO. Saccharomyces boulardii in the prevention of antibiotic associated diarrhea in children: a randomized controlled trial. Pediatr Infect Dis Soc Philipp J 2013;14:70-6.
25. Erdeve O, Tiras U, Dallar Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr 2004;50:234-6.
26. Shan LS, Hou P, Wang ZJ, et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 2013;4:329-34.
27. Bin Z, Ya-Zheng X, Zhao-Hui D, et al. The efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in children. Pediatr Gastroenterol Hepatol Nutr 2015;18:17-22.
28. Zhao HM, Ou-Yang HJ, Duan BP, et al. Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helico-bacter pylori infection in children. Zhongguo Dang Dai Er Ke Za Zhi 2014;16:230-3.
29. Destura RV. Bacillus clausii in preventing antibiotic-associated diarrhea among Filipino infants and children: a multi-center, randomized, open-label clinical trial of efficacy and safety. Unpublished.
30. Correa NBO, Peret Filho LA, Penna FJ, et al. A Randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophi-lus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005;39:385-9.
31. Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990;24:382-4.
32. Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(suppl 2):S739-42.
33. Fox MJ, Ahuja KDK, Robertson IK, et al. Can probiotics yogurt prevent diarrhea in children on antibiotics? A double-blind, randomized, placebo-controlled study. BMJ OPEN 2015;5:e006474.
34. Szymański H, Armańska M, Kowalska-Duplaga K, et al. Bifidobacter-ium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion 2008;78:13-7.
35. Ruszczyński M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children. Aliment Pharmacol Ther 2008;28:154-61.
36. Merenstein DJ, Foster J, D'Amico F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 2009;163:750-4.
37. Contardi I. Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood [Batterioterapia orale quale prevenzione della diarrea da antibiotici in eta pediatrica]. Clinica Terapeutica 1991;136: 409-13.
38. Khodadad A, Farahmand F, Najafi M, et al. Probiotics for the treatment of pediatric Helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr 2013;23:79-84.
39. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015;42:793-801.
40. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus GG in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015;42:1149-57.
41. Patro-Gołab B, Sharmi R, Szajewska H. Yogurt for treating antibiotic-associated diarrhea: systematic review and meta-analysis. Nutrition 2015;31:796-800.
42. Hempel S, Newberry S, Ruelaz A, et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep) 2011;200:1-645.